Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reportlinker Adds Middle East And Africa Neurology Devices Market Outlook to 2017

June 9, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Middle East And Africa Neurology Devices Market Outlook to 2017...

Reportlinker Adds Middle East and Africa Dental Devices Market Outlook to 2017

June 9, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Middle East and Africa Dental Devices Market Outlook to 2017...

Reportlinker Adds South and Central America Dental Devices Market Outlook to 2017

June 9, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: South and Central America Dental Devices Market Outlook to 2017...

Advertisement

Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011

June 9, 2011 1:35 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., June 9, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its majority-owned subsidiary, VGX Animal Health, Inc, will present at VetHealth...

Neurologix Presents New Confirmatory Results for Phase 2 Study of NLX-P101 in Parkinson's Disease to Recombinant DNA Advisory Committee

June 8, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FORT LEE, N.J., June 8, 2011 /- Neurologix, Inc. (OTCBB: NRGX) announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive...

New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinson's Disease And Movement Disorders (MDS)

June 8, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

FRANKFURT, Germany, June 8, 2011 /- Merz Pharmaceuticals today announced that new data on Xeomin® (incobotulinumtoxinA), a botulinum toxin type A free from accessory (complexing) proteins, will be presented at the Movement Disorder Society's (MDS) 15th International Congress of...

Wuzhou Changlian Introduces New Thermometer Series

June 8, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 8, 2011 /PRNewswire-Asia/ -- To thank customers for their continuous support of our health care products including infrared thermometers , heart beat watches, blood pressure monitors and so on, Shenzhen Wuzhou Changlian International Trading Co. has decided to offer...

Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes

June 8, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

LA JOLLA, Calif., and CAMBRIDGE, Mass., June 8, 2011 /- Regulus Therapeutics Inc ., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY ), a leading RNAi therapeutics company, today...

Advertisement

Approved Biologic Therapies in Rheumatoid Arthritis Show Further Evidence of Efficacy and Reduction in Joint Damage at the 2011 European League Against Rheumatism's Congress

June 8, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 8, 2011 /- One of the major annual rheumatology conferences, the European League Against Rheumatism's Congress (EULAR), was held May 25-28 in London.  Citeline, Inc., reviewed the trends and highlights from clinical trial results reported at EULAR, noting that approved...

Phase I Pro-Vas® Effectiveness Study Presented at AUA Meeting

June 8, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 8, 2011 /PRNewswire/ -- A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas® occlusion as a highly promising method of permanent male sterilization. The clinical study results were presented by...

Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands

June 8, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 8, 2011 /- According to a report published today by Thomson CompuMark, part of Thomson Reuters, the pharmaceutical industry has begun to adapt to stricter governmental brand name standards globally by rapidly increasing the number of trademarks it files for every new drug....

Innovative Medical Products Showcased at MD & M East Ceremony

June 8, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 8, 2011 /- The winning products in this year's Medical Design Excellence Awards (MDEA) competition, presented by UBM Canon , received their gold or silver recognition at a ceremony held today during the Medical Design & Manufacturing East (MD&M East) 2011 Conference...

LodgeNet Healthcare's eSUITE Solution Empowers Patients to Participate in Their Care

June 8, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SIOUX FALLS, S.D., June 8, 2011 /- As hospitals scramble to adopt the patient-centered focus that is at the heart of federal regulations and legislation aimed at improving healthcare in the U.S., LodgeNet Healthcare today announced the expansion of its interactive patient engagement...

Advertisement

Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products

June 8, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

EAST BRUNSWICK, N.J. and EDISON, N.J., June 8, 2011 /- Amerigen Pharmaceuticals Limited and AustarPharma, LLC today announced they had entered into a broad-based collaboration agreement regarding the development of generic oral controlled release products. Under the terms of the...

Upsher-Smith Receives Prestigious DIANA Award for Third Year in a Row

June 8, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn., June 8, 2011 /- Upsher-Smith Laboratories, Inc. announced today that it was honored with the prestigious Distribution Industry Award for Notable Achievements in Healthcare (DIANA) presented by the Healthcare Distribution Management Association (HDMA).  The award...

Vycor Medical, Inc. Completes Equity Capital Raise

June 8, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

BOCA RATON, Fla., June 8, 2011 /- On June 7, 2011, Vycor Medical, Inc.  ("Vycor" or the "Company") completed the sale of $1,570,000 in Units comprising Preferred Shares and Warrants (the "Units") to accredited investors (the "Investors").  The Units were issued pursuant to the...

National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR

June 8, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

ATLANTA, June 8, 2011 /- Elekta has collaborated with the National Comprehensive Cancer Network® (NCCN®) to integrate the NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ™) into Elekta's MOSAIQ® Oncology Information System. The collaboration offers...

Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure

June 8, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 8, 2011 /- Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for OTO-201, a sustained release gel formulation of the antibiotic ciprofloxacin, in multiple preclinical studies evaluating the...

XTRAC Laser Provides New Hope for Children with Psoriasis

June 8, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

MONTGOMERYVILLE, Pa., June 8, 2011 /- About 20,000 children in the United States under the age of 10 are diagnosed with psoriasis every year. For many, the disease goes beyond painful red, dry patches of scaly, thickened skin; the emotional side-effects are equally life...

FDA Approves Updates to Lilly's Humalog® (insulin lispro injection rDNA origin) Label

June 8, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 8, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental new drug application (sNDA) with the following updates to the Humalog label: continuous insulin infusion pump therapy in...

Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics

June 8, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., June 8, 2011 /- (NASDAQ: GRFS ) – Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, today announced that it has officially begun to merge its operations with Talecris Biotherapeutics in order to function...

Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C

June 8, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., June 8, 2011 /- Pharmasset, Inc. (Nasdaq: VRUS ) announced today the addition of three treatment cohorts to the ELECTRON trial of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The rapid and consistent antiviral effects...

iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan

June 8, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 8, 2011 /- Cellular Dynamics International, Inc. (CDI) today announced an agreement with iPS Academia Japan, Inc ., who will distribute CDI's iCell® Cardiomyocytes , the first commercially available product based on induced pluripotent stem cells (iPSCs), in...

Dilon Diagnostics Launches Acella System

June 8, 2011 3:32 am | by Diagnostic Imaging | News | Comments

(Press Release) Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800® Acella Gamma Camera system.

SNM's Image of the Year Highlights Non-Oncology Utility

June 8, 2011 3:32 am | by Diagnostic Imaging | News | Comments

The Society of Nuclear Medicine's (SNM) 2011 Image of the Year illustrates the ability of positron emission tomography/computer tomography (PET/CT) scans to identify abnormal bone reaction in patients who have received spinal fixation hardware implants.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading